Jacques Galipeau, MD, MD FRCP(C) President, ISCT Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health A few weeks ago, I gave the opening keynote address at the 2nd edition of the Dubai Stem Cell Conference (DSCC) chaired by...
There are hundreds of FACT and JACIE accredited clinical centers worldwide where thousands of dedicated technologists and their peer mates toil day-in, day-out in cell processing facilities supportive of hospital-based cell therapy programs. To this hospital-based workforce an ever-expanding...
Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The ISCT ANZ recently concluded in August 2023 an extremely successful annual...
Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health Cell and Gene Therapies (CGTs), especially at the intersection of gene-modified...
Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson, Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The Cell and Gene Therapy (CGT) field has now repeatedly demonstrated that cells - as...
From the President’s Desk: Cell and Gene Therapies and air travel Closer than you think Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of...
Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The commercialization landscape for Cell & Gene Therapies (CGTs) has benefitted from an...
Jacques Galipeau, MD FRCP(C) ISCT President Don and Marilyn Anderson, Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health In 1968, a toddler with Wiscott-Aldrich syndrome – a lethal genetic bone marrow...
From the President’s Desk: Regionalism Adds Depth to the ISCT I nternational Vision Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The former...
From the President's Desk: Inaugural Letter By: Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health You know cell & gene therapy (CGT) is in the...